Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Takeda to pay $2.4bn to settle Actos cancer suits

Will be one of the largest drug safety settlements in US history

- PMLiVE

Relief as study finds no cardiovascular risk with Januvia

FDA continues to investigate safety of numerous diabetes therapies

- PMLiVE

Pfizer falls as strong dollar and generic erosion bites

First quarter results beat analysts’ estimates but sales still sliding

Bristol-Myers Squibb (BMS) building

BMS shines in Q1, but Abilify generics cast a long shadow

Revenue up 6% but Ablify’s contribution likely to drop due to competition

- PMLiVE

Sanofi wins European approval for Lantus follow-up Toujeo

Long-acting insulin is a key part of the company's growth plans

- PMLiVE

Manjula Halai joins Wave Healthcare Communications

Moves to the med ed agency from the Royal Pharmaceutical Society

- PMLiVE

Terrence Higgins Trust pushes for HPV vaccine for men

Charity speaks out to coincide with European Immunisation Week

- PMLiVE

BioSure UK’s home HIV test goes on sale in the UK

Test delivers a diagnosis in just 15 minutes

- PMLiVE

Virgo Consumer Health & Wellbeing hires Kirsty McKinnon

Med comms agency strengthens senior team with new personal care sector lead

- PMLiVE

BIA says action plan could quadruple R&D output by 2025

Claims it could rank the UK in the global top three largest biotech clusters

- PMLiVE

Mylan pulls no punches in rejecting Teva takeover

Firm calls Israeli generics giant’s credibility into question

Sanofi reception

Sanofi gains accelerated review for rare disease drug

New pill for Fabry disease could be approved by the FDA before the end of the year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links